USA – The Trump administration is again considering a plan that could shake up the U.S. pharmaceutical industry — linking domestic drug prices to those paid by other wealthy countries. According to a Reuters report published Tuesday, this controversial proposal has re-emerged as a major concern for drugmakers, who fear it more than even the […]
USA – AstraZeneca has rejoined the Pharmaceutical Research and Manufacturers of America (PhRMA) after a two-year hiatus, signaling a renewed commitment to U.S. pharmaceutical policy and innovation. The British drugmaker had previously exited the influential lobbying group in May 2023 to explore alternative advocacy strategies at both state and federal levels. The company’s return […]
SWITZERLAND – Swiss biotech company Veraxa is set to enter the U.S. public market through a merger with Voyager Acquisition, a special purpose acquisition company (SPAC) focused on healthcare. The deal, announced recently, values the combined entity at approximately US$ 1.64 billion. Under the agreement, Veraxa’s shareholders will receive around 130 million shares of […]
DENMARK – Novo Nordisk has submitted an application to the U.S. Food and Drug Administration (FDA) seeking approval for a 25 mg oral version of its GLP-1 receptor agonist, semaglutide, intended for the treatment of overweight and obesity. This submission marks a significant milestone as it represents the first potential approval of a GLP-1 receptor […]
SOUTH KOREA – Samsung Biologics, a global leader in contract development and manufacturing (CDMO), has announced solid financial results for the first quarter of 2025. Backed by strong plant operations and growing client partnerships, the company continues to expand its production capacity and innovation in biomanufacturing. CEO John Rim highlighted the company’s achievements: “We had […]
USA – San Diego-based health tech company Biolinq has raised $100 million in a Series C funding round to propel its novel intradermal glucose sensor toward FDA approval and commercial launch. The wearable patch is designed for individuals with Type 2 diabetes who are not on insulin therapy. Alpha Wave Ventures led the investment, […]
USA – Viking Therapeutics is experiencing a resurgence in investor interest following Pfizer’s decision to discontinue its oral obesity drug candidate, danuglipron, due to safety concerns. This development has shifted attention to Viking’s promising weight-loss drug, VK2735, positioning the biotech firm as a potential frontrunner in the competitive obesity treatment market. Pfizer’s withdrawal from […]
BELGIUM – Paul Stoffels, the former Johnson & Johnson executive who took the helm at Galapagos in 2022, is set to depart from his role as CEO, marking a significant leadership change for the Belgian biotech firm. Stoffels’ exit comes as Galapagos undergoes a strategic restructuring, splitting into two separate entities. Stoffels will remain […]
USA—Bluebird Bio, a gene therapy company, has confirmed its decision to proceed with a US$ 30 million acquisition offer from private equity firms Carlyle and SK Capital Partners. This follows the failure of Ayrmid Ltd., an Ireland-based investment firm, to submit a binding proposal despite an unsolicited bid in late March. Ayrmid’s offer included […]
USA—The Trump administration has proposed a draft rule that would prohibit universities from receiving National Institutes of Health (NIH) grants if they maintain diversity, equity, and inclusion (DEI) programs or support Israel boycotts. This proposal has ignited a fierce debate over academic freedom, the role of federal funding in higher education, and the broader implications […]
USA – U.S.-based private equity firm KKR has made a public cash offer to acquire Swedish biotechnology company Biotage AB for 11.6 billion Swedish crowns, equivalent to US$ 1.22 billion. The offer, presented via KKR’s newly formed entity RWK BidCo, proposes a purchase price of 145 crowns per share, representing a 60.1% premium over Biotage’s […]
SWITZERLAND – Swiss pharmaceutical giant Roche has announced a substantial $50 billion investment in the United States over the next five years, aiming to enhance its pharmaceutical and diagnostics operations across the country. This initiative is projected to create over 12,000 jobs, including approximately 6,500 construction roles and 1,000 positions within new and expanded facilities. […]
XRP HEALTHCARE L.L.C | License Number: 2312867.01 | Dubai | © Copyright 2025 | All Rights Reserved